Back

Influence of cardiovascular inflammation on outcome and mortality in high-risk patients undergoing percutaneous mitral valve repair

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Transcatheter valvular interventions and their complications Mitral valve interventions ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Oliver Doerr

University hospital Giessen and Marburg, Giessen (Germany)

12 More presentations in this session

Presentation thumbnail
Chronic kidney disease and periprocedural outcomes among patients who underwent transcatheter mitral valve replacement (TMVR) compared to surgical mitral valve replacement:Report from NIS 2012-2014
Doctor S. Alliu (New York, US)
Presentation thumbnail
Functional status and quality of life after transcatheter mitral valve repair: a prospective cohort study and systematic review
Doctor C. Iliadis (Cologne, DE)
Abstract Slides
Presentation thumbnail
Hemodynamic characterization of right heart function to predict outcome after MitraClip
Doctor V. Mauri (Cologne, DE)
Abstract
Presentation thumbnail
Persistent iatrogenic atrial septal defect after percutaneous mitral valve repair using the MitraClip system: one step forward or two steps back.
Associate Professor M. Almalla (Aachen, DE)
Abstract
Presentation thumbnail
A simple score to predict late outcome of balloon mitral commissurotomy
Professor H. Gamra (Sousse, TN)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Transcatheter valvular interventions and their complications

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources